Central nervous system toxicity of sodium nitroprusside in treatment of patients with aortic dissection

被引:5
作者
Huang, Xueyuan [1 ]
Hou, Lingbo [1 ]
Tang, Jiarong [1 ]
Zhang, Yanmei [1 ]
Chen, Fuqiong [1 ]
Wang, Daowen [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Cardiol, Tongji Med Coll, Wuhan 430030, Peoples R China
关键词
sodium nitroprusside; toxicity; central nervous system; aortic dissection; INTERNATIONAL-REGISTRY; ENDOVASCULAR TREATMENT; HYPERTENSIVE CRISES; MANAGEMENT; CYANIDE; DISEASE; RISK;
D O I
10.1007/s11596-012-1060-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study examined the sodium nitroprusside (SNP) toxicity to central nervous system (CNS) in treatment of patients with aortic dissection (AD). The medical records of 191 AD patients who were admitted to Tongji Hospital, China, from Jan. 1998 to Feb. 2009 were retrospectively analyzed. There were 140 cases of hypertension (73.3%) and 13 cases of Marfan syndrome (6.8%) among the 191 AD patients. A total of 157 patients were given SNP treatment. The toxic reactions of CNS occurred in 18 subjects (11.5%). Most of the adverse reactions occurred on the fifth day following SNP injection. SNP infusion rate was significantly higher in patients who developed CNS toxicity. It was suggested that systemic hypertension is the most common predisposing factor for AD. The combination of SNP with a beta-receptor blocker is a medical therapy commonly used in patients with AD. Cyanide and thiocyanate toxicity from SNP treatment is always the consequence of prolonged drug infusion or relatively high dose administration.
引用
收藏
页码:927 / 930
页数:4
相关论文
共 50 条
  • [41] Treatment in childhood central nervous system demyelinating disorders
    Konuskan, Bahadir
    Anlar, Banu
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2019, 61 (11) : 1281 - +
  • [42] Progress in the treatment of fungal infections of the central nervous system
    Xuemei Li
    Xiaoxia Li
    Infection International, 2017, 6 (02) : 60 - 64
  • [43] Sodium nitrite induces acute central nervous system toxicity in guinea pigs exposed to systemic cell-free hemoglobin
    Buehler, Paul W.
    Butt, Omer I.
    D'Agnillo, Felice
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 409 (03) : 412 - 417
  • [44] Development of dyslipidemia in patients after complex treatment of central nervous system tumors in childhood
    Novikova, A. I.
    Pavlova, M. G.
    Potemkina, N. A.
    Fadeev, L. B.
    Poltavskaya, M. G.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2024, 20 (06) : 605 - 609
  • [45] Focused ultrasound treatment for central nervous system disease: neurosurgeon’s perspectives
    Chang W.S.
    Chang J.W.
    Chang, Jin Woo (jchang@yuhs.ac), 2017, Springer Verlag (07) : 107 - 114
  • [46] Superficial siderosis of the central nervous system - treatment with steroids?
    Scheid, R.
    Frisch, S.
    Schroeter, M. L.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2009, 34 (05) : 603 - 605
  • [47] Intranasal Treatment of Central Nervous System Dysfunction in Humans
    Chapman, Colin D.
    Frey, William H., II
    Craft, Suzanne
    Danielyan, Lusine
    Hallschmid, Manfred
    Schithoth, Helgi B.
    Benedict, Christian
    PHARMACEUTICAL RESEARCH, 2013, 30 (10) : 2475 - 2484
  • [48] Systemic high-dose intravenous methotrexate in patients with central nervous system metastatic breast cancer
    Bazan, F.
    Dobi, E.
    Royer, B.
    Curtit, E.
    Mansi, L.
    Menneveau, N.
    Paillard, M. J.
    Meynard, G.
    Villanueva, C.
    Pivot, X.
    Chaigneau, L.
    BMC CANCER, 2019, 19 (01)
  • [49] Central nervous system involvement in pediatric rheumatic diseases: Current concepts in treatment
    Duzova, Ali
    Bakkaloglu, Aysin
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (13) : 1295 - 1301
  • [50] The Role of Voriconazole in the Treatment of Central Nervous System Blastomycosis
    Ta, Mai
    Flowers, Stephanie A.
    Rogers, P. David
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (10) : 1696 - 1700